Development of an Arterial Pressure Monitoring Set Fixation Apparatus and Evaluation of Its Effectiveness

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study aims to develop an arterial pressure monitoring set fixation device and evaluate its effectiveness in clinical settings. The device is designed to increase the stability and comfort of arterial pressure monitoring during patient care. An experimental study will be conducted with patients requiring arterial pressure monitoring. The device's effectiveness will be evaluated by measuring fixation stability and postoperative arterial blood pressure-CVP parameters over 48 hours. The study aims to demonstrate that the new fixation device can improve patient safety and monitoring accuracy compared to the standard method using adhesive tape, thereby contributing to better clinical outcomes.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• Adult patients aged 18-80 years

• Patients undergoing arterial catheterization for invasive blood pressure and CVP monitoring

• Patients able to provide informed consent

• Hemodynamically stable patients undergoing Coronary Artery Bypass Grafting (CABG)

Locations
Other Locations
Turkey
Van Training and Research Hospital
RECRUITING
Van
Contact Information
Primary
ZEYNEP GÜRKAN, Res. Asst.
zeynepgurkan@yyu.edu.tr
+905389786500
Time Frame
Start Date: 2025-01-27
Estimated Completion Date: 2025-10-31
Participants
Target number of participants: 60
Treatments
Experimental: Arterial Pressure Monitoring Set Fixation Device Group
This group includes patients who will receive the new arterial pressure monitoring set fixation device. The device is applied postoperatively to secure arterial pressure monitoring and improve fixation stability and patient comfort over a 48-hour period.
Related Therapeutic Areas
Sponsors
Leads: Yuzuncu Yil University
Collaborators: Ataturk University

This content was sourced from clinicaltrials.gov